| STATE | RESEARCHER | INSTITUTION | SUBJECT | TERM | GRANT |
|---|
| COLORADO | | | | | |
| | Barnett, Carlton C., MD | Denver Health and Hospital Authority | The Plasma Fraction of Stored Erythrocytes Promotes Pancreas Cancer Growth | 1/1/2009 through 6/30/2012 | 7,000 |
| TOTAL # OF GRANTS: 16 | Bauer, Alison K., PhD | University of Colorado, Denver | The Role of Toll-Like Receptor 4 in Mouse Pulmonary Neoplasia | 7/1/2010 through 6/30/2014 | 0,000 |
| TOTAL FUNDING: ,392,000 | Charlesworth, Amanda, PhD | University of Colorado, Denver | Role of Zar Family Proteins in M-phase Control | 1/1/2008 through 12/31/2012 | 0,000 |
| | DiGuiseppi, Carolyn, MD, MPH, PhD | University of Colorado, Denver | Physician Training Award in Preventive Medicine | 1/1/2009 through 12/31/2012 | 0,000 |
| | DiGuiseppi, Carolyn, MD, MPH, PhD | University of Colorado, Denver | Physician Training Award in Cancer Prevention | 1/1/2012 through 6/30/2016 | 0,000 |
| | Graham, Douglas K., MD, PhD | University of Colorado, Boulder | Biologically Targeted Therapy Against Mer Tyrosine Kinase in Pediatric ALL | 7/1/2008 through 6/30/2012 | 0,000 |
| | Gump, Jacob M., PhD | University of Colorado, Denver | Manipulation of Autophagy to Improve Lymphoma Treatment | 1/1/2011 through 12/31/2013 | 0,000 |
| | Kane, Madeleine A., MD, PhD | University of Colorado, Denver | Institutional Research Grant | 1/1/2012 through 12/31/2014 | 0,000 |
| | Liu, Changwei, PhD | University of Colorado, Boulder | Mechanistic Insights for the Ubiquitin-proteasome Degradation Machinery | 7/1/2008 through 6/30/2012 | 6,000 |
| | Risendal, Betsy, PhD | University of Colorado Cancer Center | Quality of Life Health Behavior in Long-term Colon Cancer Survivors | 1/1/2009 through 12/31/2012 | 6,000 |
| | Schlaepfer, Isabel, PhD | University of Colorado, Denver | Role of Munc18c Isoforms in Cancer and Insulin Resistance | 1/1/2010 through 12/31/2012 | 0,000 |
| | Slansky, Jill E., PhD | University of Colorado, Denver | Improvement of the T cell Repertoire Responding to Tumor Vaccines | 7/1/2008 through 6/30/2012 | 8,000 |
| | Stuart, Scott, PhD | University of Colorado, Boulder | A Proteomics-based Analysis of Drug Resistance in Melanoma | 1/1/2011 through 12/31/2013 | 0,000 |
| | Taatjes, Dylan J., PhD | University of Colorado, Boulder | Regulation of p53 by the Mediator Complex | 7/1/2009 through 6/30/2013 | 2,000 |
| | Tamburini, Beth, PhD | University of Colorado, Denver | Site Specific Targeting of Cellular Immune Responses | 4/1/2010 through 3/30/2012 | ,000 |
| | Weaver, Benjamin P., PhD | University of Colorado, Boulder | MiRNA-mediated Gene Regulation in Oxidative and Hypoxic Stress Adaptation | 12/1/2011 through 11/30/2014 | 0,000 |
| CONNECTICUT | | | | | |
| | Brewer, Molly A., MD | University of Connecticut Health Center | Institutional Research Grant | 1/1/2009 through 12/31/2012 | 0,000 |
| TOTAL # OF GRANTS: 23 | Brown, Jessica A., PhD | Yale University | Do ENE-like Structures Stabilize Cellular Noncoding RNAs? | 1/1/2012 through 12/31/2014 | 0,000 |
| TOTAL FUNDING: ,877,823 | Chandhoke, Surjit K., PhD | Yale University | The Role of Molecular Motor Myo9b in Inflammatory Bowel Disease | 7/1/2009 through 6/30/2012 | 8,000 |
| | Colpitts, Sara L., PhD | University of Connecticut Health Center | Regulation of Interleukin-15 During Development and Inflammation | 7/1/2011 through 6/30/2014 | 0,000 |
| | Draheim, Kyle, PhD | Yale University | Elucidating the Significance of ILK/Integrin Tail Interactions | 1/1/2012 through 12/31/2014 | 0,000 |
| | Greco, Valentina, PhD | Yale University | Stem Cell Deregulation During Tumor Regression | 1/1/2012 through 12/31/2015 | 0,000 |
| | Harker, Elizabeth, PhD | Yale University | Retroviral Library Screening to Identify GPCR Transmembrane Inhibitors | 10/1/2011 through 9/30/2014 | 0,000 |
| | Herzon, Seth, PhD | Yale University | Synthetic and Chemical Biological Studies of Lomaiviticin A | 1/1/2011 through 12/31/2014 | 0,000 |
| | Kadan-Lottick, Nina, MD, MSPH | Yale University | Comparing Two Models of Survivorship Care: A Randomized Trial | 7/1/2010 through 6/30/2014 | 0,000 |
| | Kasinski, Andrea L., PhD | Yale University | Combinatorial miRNA Therapy for the Prevention and Treatment of Lung Cancer | 9/1/2011 through 8/31/2014 | 0,000 |
| | Kluger, Harriet M., MD | Yale University | Developing an Assay to Predict Sorafenib Response in Renal Cell Carcinoma | 1/1/2009 through 12/31/2012 | 0,000 |
| | Lynch, Thomas J., MD | Yale University | Institutional Research Grant | 1/1/2009 through 12/31/2012 | 2,823 |
| | Makoul, Gregory, PhD | St. Francis Hospital and Medical Center | Tools for Improving Colorectal Cancer Screening Rates: Multimedia vs. Print | 7/1/2008 through 6/30/2012 | ,200,000 |
| | McAuliffe, Beata, PhD | Yale University | Graduate Scholarship in Cancer Nursing Practice | 7/1/2011 through 6/30/2012 | ,000 |
| | Mehta, Shivani, BS | Yale University | Graduate Scholarship in Cancer Nursing Practice | 7/1/2011 through 6/30/2012 | ,000 |
| | Nawaz, Haq, MD, MPH | Griffin Hospital | Physician Training Award in Preventive Medicine | 1/1/2010 through 12/31/2013 | 0,000 |
| | Pope, Scott, PhD | Yale University | Regulation of Inflammation by Signal Dependent Transcriptional Repression | 1/1/2012 through 12/31/2014 | 0,000 |
| | Schulman-Green, Dena J., PhD | Yale University | Testing a Self-Guided Educational Intervention for Women With Cancer | 7/1/2008 through 6/30/2013 | 8,000 |
| | Sun, Zhaoxia, PhD | Yale University | Functional Connections Between the Tor Pathway and the Cilium in Zebrafish | 7/1/2010 through 6/30/2014 | 0,000 |
| | Sundberg, Thomas, PhD | Yale University | Role of Dishevelled Phosphorylation in Wnt Signaling | 7/1/2010 through 6/30/2013 | 0,000 |
| | Taylor, John A., MD | University of Connecticut Health Center | Inflammatory Cytokines and Bladder Cancer | 7/1/2008 through 6/30/2013 | 9,000 |
| | Tomko, Robert J., PhD | Yale University | Biochemical and Genetic Dissection of Proteasome Regulatory Particle Assembly | 7/1/2010 through 6/30/2013 | 0,000 |
| | Zhang, Yawei, MD, PhD, MPH | Yale University | Epidemiology Study of Thyroid Cancer | 1/1/2010 through 12/31/2014 | ,200,000 |
| MASSACHUSETTS | | | | | |
| | Anderson, Ana, PhD | Brigham and Women's Hospital | Manipulation of the Tim-3/galectin-9 Pathway to Restore Anti-Tumor Immunity | 1/1/2011 through 12/31/2014 | 0,000 |
| TOTAL # OF GRANTS: 100 | Anderson, Kenneth C., MD | Dana-Farber Cancer Institute | Development of Novel Myeloma Therapies | 7/1/2010 through 6/30/2015 | 0,000 |
| TOTAL FUNDING: ,071,333 | Armstrong, Scott A., MD, PhD | Children's Hospital Boston | Molecular Pathogenesis of MLL-AF9 Leukemias | 1/1/2009 through 12/31/2012 | 0,000 |
| | Bak, Peter G., PhD | Massachusetts Institute of Technology | Analysis of Dendritic Cell/T Cell Networks in Prostate Cancer | 7/1/2011 through 6/30/2014 | 0,000 |
| | Berchowitz, Luke, PhD | Massachusetts Institute of Technology | Determining the Mechanism That Restricts Translation of CLB3 During Meiosis | 7/1/2011 through 6/30/2014 | 0,000 |
| | Berger, Alice H., PhD | Dana-Farber Cancer Institute | Cross-species Genomic and Functional Analysis of KRAS-Mutant Lung Cancer | 1/1/2012 through 12/31/2014 | 0,000 |
| | Birmann, Brenda M., ScD | Brigham and Women's Hospital | A Prospective Analysis of Fatty Acids and Risk of Non-Hodgkin Lymphoma | 1/1/2011 through 12/31/2014 | 0,000 |
| | Boehmer, Ulrike, PhD | Boston University | Variations in Health Needs of Breast Cancer Survivors | 7/1/2006 through 6/30/2012 | ,138,000 |
| | Bolon, Daniel N., PhD | University of Massachusetts Medical School | Molecular Analysis of Hsp90: A Specialized Chaperone in Signal Transduction | 7/1/2008 through 6/30/2012 | 0,000 |
| | Brindle, Cheyenne S., PhD | Harvard University | Thiourea-Catalyzed Enantioselective Iodination | 1/1/2010 through 12/31/2012 | 8,000 |
| | Brisbois, Maryellen D., MSN | University of Massachusetts Medical School | Chemotherapy-induced Premature Menopause in Latina Women with Breast Cancer | 7/1/2011 through 6/30/2013 | ,000 |
| | Cai, Wenli, PhD | Massachusetts General Hospital | Electronic Cleansing for Non-cathartic Dual Energy CT Colonography | 1/1/2011 through 12/31/2014 | 0,000 |
| | Cantor, Jason R., PhD | Whitehead Institute for Biomedical Research | Systematic Identification of Amino Acid Auxotrophies in TNBC | 12/1/2011 through 11/30/2014 | 0,000 |
| | Chabner, Bruce, MD | Massachusetts General Hospital | Institutional Research Grant | 1/1/2012 through 12/31/2014 | 0,000 |
| | Charest, Alain, PhD, MSc, PhD | Tufts University | Use of Therapeutic siRNAs Against Oncogenic Signaling Pathways in Vivo | 7/1/2009 through 6/30/2013 | 0,000 |
| | Cheeseman, Iain, PhD | Whitehead Institute for Biomedical Research | Molecular Analysis of the Dynein Localization During Mitosis | 1/1/2012 through 12/31/2015 | 0,000 |
| | Chen, Aileen, MD | Dana-Farber Cancer Institute | Use of Palliative Radiation Therapy in Patients with Stage IV Lung Cancer | 7/1/2010 through 6/30/2013 | 7,000 |
| | Chiu, Yu-Hsin, PhD | Beth Israel Deaconess Medical Center | Regulation of the PI3K-Akt Pathway in Leukemia Cells for Cancer Therapy | 10/1/2010 through 9/30/2013 | 0,000 |
| | Chowdhury, Dipanjan, PhD | Dana-Farber Cancer Institute | Investigation of microRNA Induced Resistance to DNA Damaging Radiation | 1/1/2012 through 12/31/2015 | 0,000 |
| | Coffin, John M., PhD | Tufts University | Molecular Biology of Retroviruses | 1/1/2009 through 4/30/2014 | 3,333 |
| | Coffin, John M., PhD | Tufts University | Professor Research Development | 1/1/2012 through 12/31/2012 | ,000 |
| | Costa, Daniel B., MD, PhD | Beth Israel Deaconess Medical Center | Acquired Resistance to ALK Inhibitor in Lung Cancers with ALK Translocation | 7/1/2011 through 6/30/2015 | 0,000 |
| | Cui, Rutao, MD, PhD | Boston University | Signaling Pathways for UV-Induced Melanogenic Response and its Mimicking | 1/1/2009 through 12/31/2012 | 2,000 |
| | Day, Tovah, PhD | Dana-Farber Cancer Institute | Genetic and Epigenetic Determinants of Chromosomal Translocations | 1/1/2012 through 12/31/2014 | 0,000 |
| | Dedier, Julien, MD, MPH | Boston Medical Center | Ethnic Identity as a Target for Tailored Cancer Prevention Interventions | 9/1/2007 through 8/31/2012 | 2,000 |
| | Dowen, Robert H., PhD | Massachusetts General Hospital | Uncovering Regulatory Mechanisms that Govern through microRNA Function | 1/1/2012 through 12/31/2014 | 0,000 |
| | Duda, Dan G., PhD | Massachusetts General Hospital | CXCR4 Blockade as a Sensitizer in Bone Metastatic Prostate Cancer | 1/1/2011 through 12/31/2014 | 0,000 |
| | Faber, Anthony, PhD | Massachusetts General Hospital | Assessing BIM Expression as a Cause and Marker for Intrinsic Resistance | 1/1/2012 through 12/31/2012 | ,000 |
| | Faller, Douglas V., MD, PhD | Boston University | Institutional Research Grant | 1/1/2012 through 12/31/2014 | 0,000 |
| | Feinberg, Mark, MD | Brigham and Women's Hospital | Role of KLF4 in Myeloid Development and Acute Myeloid Leukemia | 7/1/2007 through 6/30/2012 | 0,000 |
| | Ferullo, Daniel, PhD | Massachusetts Institute of Technology | Rev1-mediated Translesion Synthesis of Mitochondrial DNA | 7/1/2011 through 6/30/2014 | 0,000 |
| | Gagnon, James, PhD | President and Fellows of Harvard College | Integration of Nodal Signaling and Chromatin During Cell Fate Specification | 11/1/2011 through 10/31/2014 | 0,000 |
| | Gazelle, G. Scott, MD, MPH, PhD | Massachusetts General Hospital | Lung Cancer Policy Model | 7/1/2009 through 6/30/2012 | 5,000 |
| | Georgakoudi, Irene, PhD | Tufts University | Optical Biomarkers for the Non-Invasive Detection of Early Cancer | 7/1/2009 through 6/30/2013 | 0,000 |
| | Grabiner, Brian, PhD | Whitehead Institute for Biomedical Research | Identification and Characterization of Rapamycin Sensitivity Factors in RCC | 1/1/2010 through 12/31/2012 | 0,000 |
| | Gray, Stacy W., MD | Dana-Farber Cancer Institute | Information Exposure and the Adoption of Personalized Cancer Care | 1/1/2011 through 12/31/2015 | 9,000 |
| | Gregory, Richard I., PhD | Children's Hospital Boston | Impact of RNA Uridylation in Posttranscriptional Gene Regulation | 7/1/2011 through 6/30/2015 | 0,000 |
| | Haigis, Kevin, PhD | Massachusetts General Hospital | Functional Analysis of K-Ras in Colon Cancer | 7/1/2008 through 6/30/2012 | 0,000 |
| | Haigis, Marcia, PhD | Harvard Medical School | Investigating the Role of SIRT3 in Metabolic Reprogramming | 1/1/2012 through 12/31/2015 | 0,000 |
| | Hazelbaker, Dane Z., PhD | Harvard Medical School | Regulation of Gene Expression by Proline Isomerization | 1/1/2010 through 12/31/2012 | 0,000 |
| | Higgins, Philip, MSW | Boston College | A Community-Based Palliative Care Social Work Intervention | 7/1/2010 through 6/30/2012 | ,000 |
| | Ho, Diana M., PhD | Harvard Medical School | Role of Notch Signals in Oncogenic Progression in the Mammary Epithelium | 7/1/2010 through 6/30/2013 | 0,000 |
| | Jabson, Jennifer M., MPH | Boston University | Coping and Support to Promote Health in Sexual Minority Women | 7/1/2010 through 6/30/2013 | 0,000 |
| | Jordan, Jennifer, PhD | Massachusetts Institute of Technology | Exploring the Modulation of Alkylation Damage by C21ORF56 and MYH | 2/1/2012 through 1/31/2014 | 2,000 |
| | Joseph, Natalie, MD, MPH | Boston Medical Center | A Randomized Clinical Trial to Improve HPV Immunization in Haitian Girls | 7/1/2010 through 6/30/2013 | 0,000 |
| | Justman, Quincey A., PhD | President and Fellows of Harvard College | Coordination of Cell Growth and Proliferation | 7/1/2010 through 6/30/2013 | 0,000 |
| | Karlsson, Elinor K., PhD | Harvard University | The Genetic and Evolutionary Basis of Cancer in Dogs and Humans | 7/1/2009 through 6/30/2012 | 8,000 |
| | Keating, Nancy L., MD MPH | Harvard Medical School | Effect of MA Health Insurance Reform on Breast Cancer Screening & Diagnosis | 1/1/2010 through 12/31/2012 | 1,000 |
| | Kleiman, Laura B., PhD | Massachusetts General Hospital | Radiosensitization of K-Ras Mutant Colorectal Cancers by Midostaurin | 7/1/2011 through 6/30/2014 | 0,000 |
| | Kronman, Andrea C., MD | Boston University | Effect of Patient Navigation After Cancer Screening in Depressed Women | 7/1/2009 through 6/30/2012 | 0,000 |
| | Langenau, David M., PhD | Massachusetts General Hospital | Mechanisms of Clonal Evolution and Relapse in T-cell Lymphoblastic Leukemia | 1/1/2011 through 12/31/2014 | 0,000 |
| | Liebschutz, Jane, MD, MPH | Boston Medical Center | Physician Training Award in Preventive Medicine | 1/1/2008 through 6/30/2012 | 0,000 |
| | Liebschutz, Jane, MD, MPH | Boston Medical Center | Physician Training Award in Cancer Prevention | 1/1/2011 through 6/30/2015 | 0,000 |
| | Locasale, Jason, PhD | Beth Israel Deaconess Medical Center | Regulation of Metabolic Flux in Cancer and Proliferating Cells | 1/1/2010 through 12/31/2012 | 0,000 |
| | Long, David T., PhD | Harvard Medical School | A Critical New Role for FANCM in DNA Interstrand Cross-Link Repair | 7/1/2010 through 6/30/2013 | 0,000 |
| | Mack, Jennifer, MD, MPH | Dana-Farber Cancer Institute | Understanding of Prognosis Among Parents of Children With Cancer | 1/1/2008 through 12/31/2012 | 6,000 |
| | Manning, Amity L., PhD | Massachusetts General Hospital | Rbf1-Dependent Regulation of Cell Proliferation | 7/1/2009 through 8/31/2012 | 8,000 |
| | Mao, Junhao, PhD | University of Massachusetts Medical School | Hedgehog-Gli Activation in Rhabdomyosarcoma | 1/1/2011 through 12/31/2014 | 0,000 |
| | McCarthy, Ellen P., MPH, PhD | Beth Israel Deaconess Medical Center | Asian Americans with Advanced Cancer: Preferences and Care Experiences | 7/1/2009 through 6/30/2013 | ,179,000 |
| | McCarthy, Ellen P., MPH, PhD | Beth Israel Deaconess Medical Center | Breast Cancer Screening in Older Women: Comorbidity and Competing Risks | 1/1/2010 through 12/31/2013 | 0,000 |
| | McMillan, Brian, PhD | Dana-Farber Cancer Institute | Structural and Functional Biology of E3 Ligase/Notch Ligand Interactions | 6/1/2011 through 5/31/2013 | 2,000 |
| | Mendillo, Marc L., PhD | Whitehead Institute for Biomedical Research | The Role of HSF1 in Tumorigenesis | 7/1/2009 through 6/30/2012 | 8,000 |
| | Mirica, Katherine | Massachusetts Institute of Technology | Array of Resistive Sensors for Detecting Lung Cancer in Exhaled Air | 1/1/2012 through 12/31/2014 | 0,000 |
| | Mortison, Jonathan D., PhD | Harvard University | Identification of Non-Ribosomal Tetracycline Targets in Cancer Pathogenesis | 7/1/2011 through 6/30/2014 | 0,000 |
| | Nabieva, Elena, PhD | Whitehead Institute for Biomedical Research | Computational Approaches to Human Disease: Focus on a-Synuclein | 7/1/2009 through 6/30/2012 | 8,000 |
| | Nguyen, Christine L., PhD | Dana-Farber Cancer Institute | Investigating the Role of Nek4 in Senescence and Cancer | 9/1/2009 through 8/31/2012 | 8,000 |
| | Novina, Carl D., MD, PhD | Dana-Farber Cancer Institute | Modeling RNAi Factor Function in Melanoma | 7/1/2007 through 6/30/2012 | 0,000 |
| | Orr-Weaver, Terry L., PhD | Whitehead Institute for Biomedical Research | Regulation of Chromosome Segregation and DNA Replication | 1/1/2012 through 12/31/2016 | 0,000 |
| | Ozanne, Elissa M., PhD | Massachusetts General Hospital | Risk Communication in Breast Cancer Prevention | 7/1/2006 through 6/30/2012 | 8,000 |
| | Papagiannakopoulos, Thales, PhD | Massachusetts Institute of Technology | Elucidating the Role of Circadian Rhythm Disruption in Tumorigenesis | 1/1/2012 through 12/31/2014 | 0,000 |
| | Perkins, Rebecca B., MD, MSc | Boston Medical Center | Provider Education to Improve HPV Vaccine Use in Underserved Adolescents | 7/1/2009 through 6/30/2014 | 9,000 |
| | Perry, Jennifer A., PhD | Dana-Farber Cancer Institute | The Role of Polycomb Proteins in Tumorigenesis | 7/1/2009 through 6/30/2012 | 8,000 |
| | Pirl, William F., MD | Massachusetts General Hospital | Molecular Mechanisms of Cancer-Related Symptoms in NSCLC | 7/1/2011 through 6/30/2013 | 4,000 |
| | Rahl, Peter, PhD | Whitehead Institute for Biomedical Research | The Control of Transcriptional Pause Release in Cancers Overexpressing MYC | 1/1/2011 through 12/31/2012 | 2,000 |
| | Ramsey, Matthew R., PhD | Massachusetts General Hospital | Function and Mechanism of p63 in Tumor Maintenance | 1/1/2009 through 12/31/2012 | 3,000 |
| | Samson, Leona D., PhD | Massachusetts Institute of Technology | DNA Alkylation Repair and Cancer | 7/1/2006 through 6/30/2012 | 0,000 |
| | Sarosiek, Kristopher A., PhD | Dana-Farber Cancer Institute | Predicting Tumor Chemosensitivity and Identifying Mechanisms of Resistance | 7/1/2011 through 6/30/2014 | 0,000 |
| | Selmecki, Anna M., PhD | Dana-Farber Cancer Institute | How Polyploidy and Aneuploidy Impact the Speed of Adaptation | 1/1/2011 through 12/31/2012 | 2,000 |
| | Shaffer, Donald R., PhD | Dana-Farber Cancer Institute | Improving T-Cell Immunotherapy for Cancer | 7/1/2011 through 6/30/2014 | 9,000 |
| | Shah, Khalid, PhD | Massachusetts General Hospital | Developing Novel Targeted Therapies for Brain Tumors | 7/1/2008 through 6/30/2012 | 0,000 |
| | Sinkevicius, Kerstin, PhD | Children's Hospital Boston | Examination of the Cancer Stem Cell Hypothesis in Human Lung Tumors | 7/1/2009 through 6/30/2012 | 8,000 |
| | Spardy, Nicole, PhD | Dana-Farber Cancer Institute | Dissecting the Mechanisms of CDK8-induced Cell Transformation | 7/1/2011 through 6/30/2014 | 0,000 |
| | Stegmaier, Kimberly, MD | Dana-Farber Cancer Institute | Validating Syk as a Target for AML Therapy | 7/1/2009 through 6/30/2013 | 0,000 |
| | Stossel, Thomas P., MD | Brigham and Women's Hospital | American Cancer Society Clinical Research Professorship | 7/1/2007 through 6/30/2012 | 0,000 |
| | Stossel, Thomas P., MD | Brigham and Women's Hospital | Professor Research Development | 1/1/2012 through 6/30/2012 | ,000 |
| | Stout, Natasha K., PhD | Harvard Pilgrim Health Care | Community Breast MRI Screening: Clinical and Economic Implications | 1/1/2010 through 12/31/2014 | 8,000 |
| | Thoreen, Carson C., PhD | Dana-Farber Cancer Institute | Development of Selective Inhibitors of the mTORC2 Signaling Complex | 7/1/2010 through 6/30/2013 | 0,000 |
| | Tjia, Jennifer, MD | University of Massachusetts Medical School | Patient Centered Prescribing for Medically Complex Older Adults with Cancer | 7/1/2011 through 6/30/2013 | 1,000 |
| | Traeger, Lara N., PhD | Massachusetts General Hospital | Depression and Mental Healthcare Needs in Older Lung Cancer Patients | 1/1/2011 through 12/31/2013 | 0,000 |
| | Tseng, Jennifer F., MD, MPH | University of Massachusetts Medical School | Determining the Optimal Sequencing Strategy for Pancreatic Cancer Treatment | 1/1/2010 through 12/31/2014 | 8,000 |
| | Walter, Johannes, PhD | Harvard Medical School | A Single-molecule View of Eukaryotic DNA Replication | 7/1/2008 through 6/30/2012 | 0,000 |
| | Wei, Wenyi, PhD | Beth Israel Deaconess Medical Center | Functional Analysis of the Tumor Suppressor Role of Fbw7 in T-ALL | 1/1/2012 through 12/31/2015 | 0,000 |
| | Weinstock, David M., MD | Dana-Farber Cancer Institute | Functional Oncogene Identification in Hematologic Neoplasms | 7/1/2010 through 6/30/2014 | 0,000 |
| | Wharam, James F., MB, BCh, BAO | Harvard Pilgrim Health Care | Impact of High Deductible Health Plans on Disparities in Cancer Screening | 1/1/2010 through 12/31/2012 | 8,000 |
| | Williams, Eric, PhD | Massachusetts Institute of Technology | The Role of Sirt1 in Oncogenesis and Tumor Suppression in Skin Cancer | 7/1/2011 through 6/30/2014 | 0,000 |
| | Zalis, Michael E., MD | Massachusetts General Hospital | Clinical Evaluation of Non-Cathartic, Computer-Aided CT Colonography | 7/1/2008 through 6/30/2012 | 2,000 |
| | Zhao, Dezheng, PhD | Beth Israel Deaconess Medical Center | Role of Orphan Nuclear Receptor Nurr1 in Angiogenesis | 7/1/2007 through 6/30/2012 | 0,000 |
| | Zhu, Zhenglun (Jerry), MD, PhD | Brigham and Women's Hospital | Molecular Mechanisms Underlying Acute Lymphocytic Leukemia | 1/1/2011 through 12/31/2014 | 0,000 |
| | Zid, Brian, PhD | Harvard University | Mechanisms of Translational Regulation Under Nutrient Starvation | 1/1/2011 through 12/31/2013 | 0,000 |
| | Zou, Lee, PhD | Massachusetts General Hospital | DNA-Damage Regulation of the Checkpoint Activator TopBP1 | 1/1/2009 through 12/31/2012 | 0,000 |
| NEW HAMPSHIRE | | | | | |
| | Berwin, Brent, PhD | Dartmouth College | Ovarian Cancer Inhibition by Depletion of Myeloid-Derived Suppressor Cells | 7/1/2010 through 6/30/2014 | 0,000 |
| TOTAL # OF GRANTS: 7 | Dmitrovsky, Ethan, MD | Dartmouth College | Bidirectional Translational Research for Lung Cancer | 7/1/2008 through 6/30/2013 | 0,000 |
| TOTAL FUNDING: ,001,510 | Ernst, Patricia, PhD | Dartmouth College | Molecular Pathways Regulated by the MLL Proto-Oncogene During Lymphopoiesis | 1/1/2011 through 12/31/2014 | 0,000 |
| | Godek, Kristina M., PhD | Dartmouth Medical School | Investigating Chromosomal Instability in Cancer Stem Cells | 1/1/2012 through 12/31/2014 | 0,000 |
| | Israel, Mark A., MD | Dartmouth College | Institutional Research Grant | 1/1/2010 through 12/31/2012 | 0,000 |
| | Onega, Tracy, PhD | Dartmouth-Hitchcock Medical Center | Assessing and Improving Mammography (AIM) | 4/1/2011 through 3/31/2012 | ,510 |
| | Turk, Mary Jo, PhD | Dartmouth College | Tumor-Specific T cell Memory and the Role of Autoimmunity | 1/1/2012 through 12/31/2015 | 0,000 |
| NEW YORK | | | | | |
| | Abate-Shen, Cory, PhD | Columbia University Medical Center | Molecular Determinants of Prostate Cancer Progression | 1/1/2012 through 12/31/2016 | 0,000 |
| TOTAL # OF GRANTS: 94 | Agalliu, Ilir, MD, ScD | Albert Einstein College of Medicine, Yeshiva University | Insulin/IGF-axis and Aggressive Prostate Cancer | 7/1/2011 through 6/30/2015 | 9,000 |
| TOTAL FUNDING: ,521,000 | Applegate, Mary, MD, MPH | State University of New York at Albany | Physician Training Award in Preventive Medicine | 1/1/2010 through 12/31/2013 | 0,000 |
| | Barnhart, Meredith J., MS, LMSW | Fordham University | Enhancing Concurrent Child and Caregiver Oncology Treatment | 7/1/2011 through 6/30/2013 | ,000 |
| | Basch, Charles E., PhD | Columbia University | Promoting CRC Screening in a Hard-To-Reach, Low-Income Minority Population | 1/1/2009 through 12/31/2013 | ,122,000 |
| | Blander, Julie M., PhD | Mount Sinai School of Medicine | Helping Immune Responses to Tumors with Signals from Toll-like Receptors | 7/1/2009 through 6/30/2013 | 0,000 |
| | Blinder, Victoria S., MD | Memorial Sloan-Kettering Cancer Center | Ethnic Differences in the Impact of Breast Cancer on Work, Finances, andQoL | 1/1/2011 through 12/31/2015 | 3,000 |
| | Boerckel, Win, MSW, MBA | Cancer Care of Long Island | Master's Training Grant in Clinical Oncology SW | 7/1/2011 through 6/30/2012 | ,000 |
| | Bos, Paula D., PhD | Memorial Sloan-Kettering Cancer Center | T Regulatory Cell Function In Breast Cancer Progression and Metastasis | 7/1/2011 through 6/30/2014 | 0,000 |
| | Buchkovich, Nicholas, PhD | Cornell University | ESCRTing Receptors for Degradation | 1/1/2012 through 12/31/2014 | 0,000 |
| | Cagan, Ross, PhD | Mount Sinai School of Medicine | A Novel Class of Therapeutic Kinase Inhibitors for Treatment of MEN2 | 1/1/2011 through 12/31/2015 | ,200,000 |
| | Callahan, Kevin P., PhD | University of Rochester | Molecular Genetic Analysis of Parthenolide-Based Leukemia Stem Cell Death | 1/1/2010 through 12/31/2012 | 0,000 |
| | Chan, Edward L., MD | State University of New York at Stony Brook | Ron As An Adjunct Biomarker for EGFR Expressing Head and Neck Cancer | 7/1/2009 through 6/30/2014 | 5,000 |
| | Cheng, Emily, MD | Memorial Sloan-Kettering Cancer Center | Genetic Programs of Non-Apoptotic Cell Death | 1/1/2010 through 12/31/2013 | 0,000 |
| | Ciesielski, Michael J., PhD | Health Research Inc., Roswell Park Cancer Institute | Anti-glioma Immunotherapy Using the Survivin Molecular Mimic, SVN53-67/M57 | 7/1/2011 through 6/30/2015 | 0,000 |
| | Coniglio, Salvatore J., PhD | Albert Einstein College of Medicine, Yeshiva University | Mechanisms of Microglia-induced Glioma Invasion | 10/1/2011 through 9/30/2013 | 2,000 |
| | Cook, Peter, PhD | Memorial Sloan-Kettering Cancer Center | Molecular Mechanisms Controling Cell Senescence Within the Adult Brain | 1/1/2012 through 12/31/2013 | 2,000 |
| | Crew, Katherine D., MD | Columbia University | Green Tea for Breast Cancer Chemoprevention: Surrogate Endpoint Biomarkers | 4/1/2008 through 3/31/2013 | 9,000 |
| | Cullen, Paul J., PhD | State University of New York at Buffalo | Regulatory Proteins of a Cdc42-Dependent MAP Kinase Pathway in Yeast | 7/1/2007 through 6/30/2012 | 0,000 |
| | Das, Tirtha K., PhD | Mount Sinai School of Medicine | Using Drosophila to Discover Metastasis Modifiers and Therapeutics for MEN2 | 7/1/2011 through 6/30/2014 | 0,000 |
| | Dasgupta, Ramanuj, PhD | New York University School of Medicine | A Targeted Screen for Novel Chemical Modulators of Wnt Signaling | 7/1/2011 through 6/30/2015 | 0,000 |
| | David, Gregory, PhD | New York University Medical Center | Repressed Chromatin as a Barrier to Oncogenic Transformation | 1/1/2008 through 12/31/2012 | 0,000 |
| | de Lange, Titia, PhD | The Rockefeller University | The Role of Telomere Dynamics in Human Cancer | 1/1/2010 through 12/31/2014 | 0,000 |
| | Dhingra, Lara, PhD | Beth Israel Medical Center | Quality Improvement for Symptom Control in Underserved Chinese Patients | 7/1/2009 through 6/30/2014 | ,762,000 |
| | Di Cristofano, Antonio, PhD | Albert Einstein College of Medicine, Yeshiva University | In vivo Analysis of Molecular Mechanisms of Endometrial Cancer Initiation | 1/1/2009 through 12/31/2012 | 0,000 |
| | Dickens, Richard, LCSW | Cancer Care, Inc. | Master's Training Grant in Clinical Oncology SW | 7/1/2011 through 6/30/2012 | ,000 |
| | Einstein, Mark H., MD | Albert Einstein College of Medicine, Yeshiva University | Epigenetic Determinants of 1/1/2008 Progression to High Grade through Cervical Neoplasia | 1/1/2008 through 12/31/2012 | 9,000 |
| | Erlebacher, Adrian, MD, PhD | New York University | Mechanisms of Effector Phase Tolerance Towards the Allogeneic Fetus | 7/1/2010 through 6/30/2014 | 0,000 |
| | Feigin, Michael E., PhD | Cold Spring Harbor Laboratory | Role of Scribble in Breast Cancer Initiation and Maintenance | 1/1/2011 through 12/31/2012 | 2,000 |
| | Fiscella, Kevin, MD, MPH | University of Rochester | Primary Care-Based Randomized Trial to Reduce Cancer Screening Disparities | 1/1/2008 through 12/31/2012 | ,060,000 |
| | Ford, Jennifer S., PhD | Memorial Sloan-Kettering Cancer Center | Identity Development and Adaptation Among Adolescent Cancer Survivors | 7/1/2007 through 6/30/2012 | 9,000 |
| | Frescas, David, PhD | The Rockefeller University | Dissecting the Molecular Role of TIN2 in Dyskeratosis Congenita and Cancer | 1/1/2010 through 12/31/2012 | 0,000 |
| | Garland, Elizabeth J., MD, MS | Mount Sinai School of Medicine | Physician Training Award in Cancer Prevention | 1/1/2011 through 6/30/2015 | 0,000 |
| | Goetz, Sarah, PhD | Memorial Sloan-Kettering Cancer Center | Characterizing the Requirement for Cilia in PDGFRalpha Signaling In Vivo | 7/1/2008 through 6/30/2012 | 8,000 |
| | Gold, Heather T., PhD | New York University School of Medicine | New Breast Cancer Radiotherapy Technology: Impact on Disparities in Access | 1/1/2010 through 12/31/2012 | 1,000 |
| | Gonzalez, Ruben L., PhD | Columbia University | The Structural Dynamics of Translation Termination and Ribosome Recycling | 1/1/2009 through 12/31/2012 | 8,000 |
| | Grudzen, Corita R., MD, MSHS | Mount Sinai School of Medicine | ED-based Palliative Care Consultation for Patients with Advanced Cancer | 7/1/2010 through 6/30/2015 | 9,000 |
| | Gudkov, Andrei V., PhD | Health Research Inc., Roswell Park Cancer Institute | Roswell Park Cancer Institute Institutional Research Grant | 1/1/2012 through 12/31/2013 | 0,000 |
| | Halfon, Marc S., PhD | State University of New York at Buffalo | Mechanisms for Specificity in Receptor Tyrosine Kinase Signaling | 1/1/2009 through 12/31/2012 | 0,000 |
| | Halmos, Balazs, MD | Columbia University | Sensitivity and Resistance to HER Family Tyrosine Kinase through inhibitors | 1/1/2009 through 12/31/2012 | 0,000 |
| | Hernando, Eva M., PhD | New York University | Mechanisms of Mesenchymal Transformation and Leiomyosarcoma-genesis | 7/1/2008 through 6/30/2012 | 6,000 |
| | Hsieh, James J., MD, PhD | Memorial Sloan-Kettering Cancer Center | Molecular Mechanisms of Checkpoint Control in Leukemia | 1/1/2009 through 12/31/2012 | 0,000 |
| | Huang, Ziwei, PhD | State University of New York Upstate Medical University | Institutional Research Grant | 1/1/2011 through 12/31/2013 | 0,000 |
| | Iyer, Renuka V., MD | Health Research Inc., Roswell Park Cancer Institute | Targeted Therapies in Hepatocellular Cancer | 1/1/2008 through 12/31/2012 | 9,000 |
| | Januszyk, Kurt, PhD | Memorial Sloan-Kettering Cancer Center | Investigations into How the Exosome Recognizes and Degrades RNA | 7/1/2010 through 6/30/2013 | 0,000 |
| | Joyce, Johanna, PhD | Memorial Sloan-Kettering Cancer Center | Interleukins, Cathepsins and Macrophages in the Tumor Microenvironment | 1/1/2012 through 12/31/2015 | 0,000 |
| | Katt, William, PhD | Cornell University | Glutaminase Inhibition as a Method of Breast Cancer Control | 7/1/2010 through 6/30/2013 | 0,000 |
| | Krogsgaard, Michelle, PhD | New York University | Engineering T-cells with Enhanced Sensitivity to Melanoma Antigens | 1/1/2009 through 12/31/2012 | 0,000 |
| | Krug, Laurie T., PhD | State University of New York at Stony Brook | Regulation of Gammaherpesvirus Latency by NF-kappaB Signaling | 7/1/2011 through 6/30/2015 | 0,000 |
| | Lally, Robin, PhD, RN | State University of New York at Buffalo | Internet-based Psychoeducation to Promote Initial Breast Cancer Adjustment | 7/1/2011 through 6/30/2016 | 7,000 |
| | Lane, Dorothy, MD | State University of New York at Stony Brook | Physician Training Award in Preventive Medicine | 1/1/2009 through 12/31/2012 | 0,000 |
| | Lane, Dorothy, MD | State University of New York at Stony Brook | Physician Training Award in Cancer Prevention | 1/1/2012 through 6/30/2016 | 0,000 |
| | Lee, Min-Ho, PhD | State University of New York at Albany | The Coordinate Translational Control of Multiple mRNA Targets in C. Elegans | 7/1/2007 through 6/30/2012 | 5,000 |
| | Lesokhin, Alexander, MD | Memorial Sloan-Kettering Cancer Center | Targeting Myeloid Derived Suppressor Cells in Immunotherapy for Melanoma | 1/1/2011 through 12/31/2015 | 9,000 |
| | Li, Ming, PhD | Memorial Sloan-Kettering Cancer Center | Transforming Growth Factor-beta1 Control of Tumor Immune Evasion | 1/1/2012 through 12/31/2015 | 0,000 |
| | Ligon, Lee, PhD | Rensselaer Polytechnic Institute | The Role of Heterotypic Cell-Cell Adhesion in the Metastatic Cascade | 7/1/2010 through 6/30/2014 | 0,000 |
| | Lin, Jenny J., MD | Mount Sinai School of Medicine | Improving Breast Cancer Survivor Medication Adherence Through Education | 7/1/2010 through 6/30/2013 | 0,000 |
| | Lyman, Andrea, MD, MSc, MS | New York City Department of Health | Physician Training Award in Preventive Medicine | 1/1/2010 through 12/31/2013 | 0,000 |
| | Mahoney, Martin, MD, PhD | Health Research Inc., Roswell Park Cancer Institute | Physician Training Award in Preventive Medicine | 1/1/2010 through 12/31/2014 | 0,000 |
| | Mao, Yinghui, PhD | Columbia University | Microtubule Regulation in Mitosis | 1/1/2009 through 12/31/2012 | 0,000 |
| | Marchenko, Natalia, PhD | State University of New York at Stony Brook | Degrading Stabilized Mutant p53 in Cancer - A Novel Targeted Strategy | 7/1/2011 through 6/30/2015 | 0,000 |
| | Meneses, Patricio I., PhD | Fordham University | Infectious Process of HPV, Cervical Cancer's Etiologic Agent | 1/1/2012 through 12/31/2015 | 0,000 |
| | Mistry, Sucharita J., PhD | Mount Sinai School of Medicine | Targeting Stathmin-Tubulin Interaction In Breast Cancer | 10/1/2010 through 9/30/2014 | 0,000 |
| | Mohamed, Nihal E., PhD | Mount Sinai School of Medicine | An Educational Intervention for Patients with Invasive Bladder Cancer | 7/1/2011 through 6/30/2016 | 2,000 |
| | Montagna, Cristina, PhD | Albert Einstein College of Medicine, Yeshiva University | Comparative Genetic Analysis of Breast Cancer Tumor Progression | 1/1/2011 through 12/31/2014 | 0,000 |
| | Nikiforov, Mikhail A., PhD | Health Research Inc., Roswell Park Cancer Institute | Targeting C-MYC with Small Molecules as a Novel Anti-Melanoma Therapy | 7/1/2010 through 6/30/2014 | 0,000 |
| | Pagano, John M., PhD | Cornell University | Regulation of RNA Polymerase II Activity Through Promoter-Proximal Pausing | 1/1/2012 through 12/31/2014 | 0,000 |
| | Parekh, Niyati, PhD | New York University | The Cancer, Insulin Resistance, and Lifestyle (CIRCLE) Study | 1/1/2012 through 12/31/2015 | 0,000 |
| | Park, Peter K., MD, PhD | Memorial Sloan-Kettering Cancer Center | Enantioselective Total Synthesis of the Cytotoxic Agent Providencin | 1/1/2011 through 12/31/2013 | 0,000 |
| | Preall, Jonathan B., PhD | Cold Spring Harbor Laboratory | Identifying Novel ncRNAs Involved in Epigenetic Control and Carcinogenesis | 10/1/2011 through 9/30/2014 | 0,000 |
| | Raghavan, Srikala, PhD | Columbia University | Investigating the Role of Integrins in Organizing the Extracellular Matrix | 1/1/2012 through 12/31/2015 | 5,000 |
| | Rohrschneider, Monica R., PhD | New York University - Skirball Institute | Identification and Analysis of Gastrulation Control Genes in C. Elegans | 1/1/2010 through 12/31/2012 | 0,000 |
| | Rosenberg, Miriam, PhD | New York University | Evolution and Plasticity of Developmental Gene Networks | 8/15/2011 through 8/14/2012 | ,000 |
| | Santa Maria Guerra, Sergio R., PhD | New York University School of Medicine | Regulation of the Rad51 Recombinase and Maintenance of Genome Stability | 1/1/2011 through 12/31/2013 | 0,000 |
| | Schmidt, Valentina A., PhD | State University of New York at Stony Brook | Role of GTPase-activating Proteins in Liver Carcinogenesis | 1/1/2009 through 12/31/2012 | 0,000 |
| | Sharcot, Susan, MSW | Health Research Inc., Roswell Park Cancer Institute | Master's Training Grant in Clinical Oncology SW | 7/1/2011 through 6/30/2012 | ,000 |
| | Shi, Hua, PhD | State University of New York at Albany | Aptamer-mediated Sub-molecular Modulation of Estrogen Receptor Activities | 7/1/2009 through 6/30/2013 | 7,000 |
| | Shuman, Stewart, MD, PhD | Memorial Sloan-Kettering Cancer Center | RNA Repair | 1/1/2010 through 12/31/2014 | 0,000 |
| | Smolka, Marcus, PhD | Cornell University | Cellular Responses to DNA Replication Stress | 7/1/2011 through 6/30/2015 | 0,000 |
| | Snow, Alison, MSW | City College of the City University of New York | Hypnosis for Treatment of Pain and Anxiety in Patients Receiving BMBX | 7/1/2010 through 6/30/2012 | ,000 |
| | Snow, Alison, MSW | Beth Israel Medical Center | Master's Training Grant in Clinical Oncology SW | 7/1/2011 through 6/30/2012 | ,000 |
| | Sun, Jun, PhD | University of Rochester | The Role of Bacterial Effector Protein AvrA in Colonic Tumorigenesis | 1/1/2009 through 12/31/2012 | 0,000 |
| | Sussner, Katarina M., PhD, MPH | Mount Sinai School of Medicine | Factors Related to BRCA Genetic Counseling in Diverse Latinas | 7/1/2009 through 6/30/2012 | 8,000 |
| | Tonorezos, Emily S., MD | Memorial Sloan-Kettering Cancer Center | Diet and Insulin Resistance in Survivors of Childhood Leukemia | 7/1/2011 through 6/30/2014 | 0,000 |
| | Trombetta, Eduardo S., PhD | New York University | Cross Presentation and Immunogenicity of Protein Antigens | 7/1/2007 through 6/30/2012 | 0,000 |
| | Verma, Amit, MD | Albert Einstein College of Medicine, Yeshiva University | Inhibition of TGF-beta Signaling as a Therapeutic Strategy in MDS | 7/1/2009 through 6/30/2013 | 9,000 |
| | Warren, Graham, MD, PhD | Health Research Inc., Roswell Park Cancer Institute | Pathways Critical to Nicotine Mediated Decreases in Cancer Therapy Response | 1/1/2011 through 12/31/2015 | 9,000 |
| | Weisberg, Stuart P., MD, PhD | Columbia University | The Role of ZFX in Self-Renewal of Malignant Lymphoid and Myeloid Cells. | 7/1/2009 through 6/30/2012 | 1,000 |
| | Wigler, Michael H., PhD | Cold Spring Harbor Laboratory | Control of Cell Proliferation | 1/1/2011 through 8/31/2012 | 7,000 |
| | Wigler, Michael H., PhD | Cold Spring Harbor Laboratory | Professor Research Development | 1/1/2012 through 12/31/2012 | ,000 |
| | Will, Britta, PhD | Albert Einstein College of Medicine, Yeshiva University | SATB1-dependent Epigenetic Regulation of Leukemia Initiating Cells | 9/1/2011 through 8/31/2014 | 0,000 |
| | Wisnivesky, Juan P., MD, DrPH | Mount Sinai School of Medicine | Determinants of Disparities in Diagnosis and Treatment of Lung Cancer | 7/1/2007 through 6/30/2012 | 7,000 |
| | Wu, Lisa M., PhD, MPhil, MS | Mount Sinai School of Medicine | Computerized Cognitive Training Program for Prostate Cancer Patients | 1/1/2012 through 12/31/2014 | 0,000 |
| | Zhao, Xiaolan, PhD | Memorial Sloan-Kettering Cancer Center | Studying the Roles of Sumoylation in the Maintenance of Genomic Stability | 1/1/2012 through 12/31/2015 | 0,000 |
| OREGON | | | | | |
| | Buckley, David I., MD | Oregon Health and Science University | Cancer Prevention and Screening for Disabled Adults in Rural Primary Care | 1/1/2008 through 12/31/2012 | 6,000 |
| TOTAL # OF GRANTS: 12 | Carney, Patricia A., PhD | Oregon Health and Science University | Assessing and Improving Mammography (AIM) | 2/1/2011 through 3/31/2012 | ,454 |
| TOTAL FUNDING: ,000,454 | Carney, Patricia A., PhD | Oregon Health and Science University | Health Insurance and Cancer Screening in Rural Oregon | 7/1/2007 through 6/30/2012 | 2,000 |
| | Fischer, Jared M., PhD | Oregon Health and Science University | Modeling Sporadic Cancer in the Mouse Intestine | 1/1/2011 through 12/31/2013 | 0,000 |
| | Freitag, Michael, PhD | Oregon State University | Centromere Assembly and Maintenance | 1/1/2008 through 12/31/2012 | 9,000 |
| | Hansen, Lissi, PhD | Oregon Health and Science University | Symptoms and Quality of Life in Patients with Advanced Liver Cancer | 7/1/2010 through 6/30/2012 | 4,000 |
| | Langer, Ellen M., PhD | Oregon Health and Science University | The Role of Snail in Endothelial Commitment and Vascular Development | 1/1/2010 through 12/31/2012 | 0,000 |
| | Lee-Lin, Frances F., PhD, RN, OCN, CNS | Oregon Health and Science University | Targeted Breast Health Educational Program (TBHEP) for Chinese Americans | 1/1/2009 through 12/31/2013 | 3,000 |
| | Lyons, Karen S., PhD | Oregon Health and Science University | The Family Living with Lung Cancer: Perceptions and Outcomes | 7/1/2007 through 6/30/2012 | 7,000 |
| | Mustacich, Debbie J., PhD | Oregon State University | Mechanism of Cisplatin-Induced Neuropathy and Use of Adjuvant Vitamin E | 1/1/2011 through 12/31/2014 | 0,000 |
| | Smith, Jeanene A., MD, MPH | Oregon Health Policy and Research | The Impact of Insurance Coverage on Cancer Care: A Randomized Trial | 1/1/2011 through 12/31/2014 | 0,000 |
| | Troll, Joshua V., PhD | University of Oregon, Eugene | Roles of the Microbiota and Notch Signaling in Specifying Cell Fate | 11/1/2011 through 10/31/2014 | 0,000 |
| VERMONT | | | | | |
| | Geller, Berta, EdD | University of Vermont and State Agriculture College | Assessing and Improving Mammography (AIM) | 4/1/2011 through 3/31/2012 | 1,666 |
| TOTAL # OF GRANTS: 3 | Holmes, Chris, MD, PhD | University of Vermont | Platelet Modulation in the Control of Angiogenesis | 7/1/2008 through 6/30/2013 | 7,000 |
| TOTAL FUNDING: 6,666 | Maher, Robyn, PhD | University of Vermont and State Agriculture College | Kinetic Characterization of the T4 Bacteriophage DNA Recombinase, UVSX | 7/1/2009 through 6/30/2012 | 8,000 |
| | | | | | |
| WASHINGTON | | | | | |
| | Arroyo, Jason D., PhD | Fred Hutchinson Cancer Research Center | Extracellular miR-141 in Prostate Cancer | 7/1/2010 through 6/30/2013 | 0,000 |
| TOTAL # OF GRANTS: 19 | Brennan, Greg, PhD | Fred Hutchinson Cancer Research Center | Inhibition of the interferon-induced PKR by RhCMV TRS1 | 1/1/2012 through 12/31/2013 | 2,000 |
| TOTAL FUNDING: ,781,715 | Buist, Diana S., PhD, MPH | Group Health Cooperative | Assessing and Improving Mannography (AIM) | 4/1/2011 through 3/31/2012 | 1,287 |
| | Buist, Diana S., PhD, MPH | Group Health Cooperative | Effectiveness of Healthcare System Outreach for Breast Cancer Screening | 7/1/2011 through 6/30/2013 | 7,000 |
| | Chevillet, John R., PhD | Fred Hutchinson Cancer Research Center | MicroRNA Biomarkers for Minimally Invasive Early Cancer Detection | 7/1/2009 through 6/30/2012 | 8,000 |
| | Deyter, Gary M., PhD | Fred Hutchinson Cancer Research Center | Elucidation of Mechanisms that Exclusively Localize Centromeres | 7/1/2011 through 6/30/2014 | 0,000 |
| | DiMaio, Terri, PhD | University of Washington | Regulation of Angiogenesis by Kaposi's Sarcoma-Associated Herpesvirus | 7/1/2010 through 6/30/2012 | 2,000 |
| | Hughes, Bridget T., PhD | Fred Hutchinson Cancer Research Center | Mechanisms Regulating Cyclin E Stability and Tumorigenesis | 1/1/2010 through 2/8/2013 | 0,000 |
| | King, Mary-Claire, PhD | University of Washington | ACS-Walt Disney Family Foundation Professor for Breast Cancer Research | 1/1/2010 through 12/31/2014 | 0,000 |
| | Lao, Victoria, MD, PhD | Fred Hutchinson Cancer Research Center | Novel Molecular Signatures of Colorectal Cancer | 8/1/2011 through 7/31/2013 | ,000 |
| | Magnuson, Nancy, PhD | Washington State University | Institutional Research Grant | 1/1/2010 through 12/31/2012 | 0,000 |
| | Merz, Alexey, PhD | University of Washington | Molecular Basis of Endolysosomal Traffic Control | 1/1/2010 through 12/31/2013 | 0,000 |
| | Miglioretti, Diana, PhD | Group Health Cooperative | Assessing and Improving Mammography (AIM) | 4/1/2011 through 3/31/2012 | 1,628 |
| | Miller, Chris P., PhD | University of Washington | Erythropoietin and Cancer: Insights from Archival Clinical Tumor Samples | 7/1/2009 through 6/30/2014 | 3,800 |
| | Nghiem, Paul, MD, PhD | University of Washington | Merkel Cell Carcinoma: Defining Key Genetic and Prognostic Factors | 7/1/2008 through 6/30/2012 | 0,000 |
| | Nickerson, Daniel, PhD | University of Washington | Regulatory Mechanisms of SNARE-Mediated Membrane Fusion | 1/1/2010 through 12/31/2012 | 0,000 |
| | Paguirigan, Amy L., PhD | Fred Hutchinson Cancer Research Center | Microfluidic Methods for Studying Leukemic Stem Cell Drug Resistance | 10/1/2009 through 9/30/2012 | 8,000 |
| | Robison, Jeanne M., MN | Washington State University | The Sexual Health and Sexual Function of Colon Cancer Survivors | 7/1/2011 through 6/30/2013 | ,000 |
| | Weinmann, Amy S., PhD | University of Washington | Defining the T-box Domain's Role in Developmental Epigenetic Events | 1/1/2009 through 12/31/2012 | 0,000 |
